MedPath

n-blinded Multicenter Study to Assess the Safety and Efficacy of Robotic-assisted (da Vinci surgical system, DVSS) Laparoscopic Partial Nephrectomy for Renal Cell Carcinoma Patients

Not Applicable
Conditions
cT1 Renal Canser
Registration Number
JPRN-UMIN000013964
Lead Sponsor
Kobe University Graduate School of Medicine
Brief Summary

The achievement rate of the primary endpoint was 91.3% (95%CI:84.1-95.9%). It was significantly higher than the preset threshold (23.3%).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
118
Inclusion Criteria

Not provided

Exclusion Criteria

1)multiple cancer 2)history of kidney transplantation. 3)therapies for renal cell cancer in the past 6 months. 4)unable to withdrawal of anticoagulation 5)anemia or hemorrhagic tendency requiring transfusion 6)obesity(Body Mass Index:BMI>=35) 7)dialysis patient. 8)pregnant, suspected of being pregnant, or lactating woman. 9)difficult to participate the study due to psychiatric disorder or psychological symptom. 10)inappropriate by the investigator or sub-investigator at the hospital (site) for any other reasons.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Preservation of renal function and radical resection of renal cell carcinoma (negative surgical margin and ischemic time <25min.)
Secondary Outcome Measures
NameTimeMethod
-Surgical time -Console time -Intraoperative blood loss -Renal function (eGFR) -Complete rate of the robotic-assisted laparoscopic partial nephrectomy -Conversion to open surgery or laparoscopic surgery -Postoperative recovery process (the date of first intraoral intake, postoperative hospital stay) -Overall survival period -Recurrence-free survival time -Perioperative (during and early postoperative) adverse events (urine leakage, hemorrhage, etc.) -Postoperative adverse events -Late postoperative adverse events (cardiac, cerebrovascular diseases) -Mechanical defects
© Copyright 2025. All Rights Reserved by MedPath